Gregory I. Frost
2007
In 2007, Gregory I. Frost earned a total compensation of $402K as Vice President and Chief Scientific Officer at Halozyme Therapeutics, a 20% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $67,600 |
|---|---|
| Option Awards | $72,668 |
| Salary | $261,467 |
| Other | $290 |
| Total | $402,025 |
Frost received $261.5K in salary, accounting for 65% of the total pay in 2007.
Frost also received $67.6K in non-equity incentive plan, $72.7K in option awards and $290 in other compensation.
Rankings
In 2007, Gregory I. Frost's compensation ranked 6,707th out of 8,700 executives tracked by ExecPay. In other words, Frost earned more than 22.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,707 out of 8,700 | 23rd |
Division Manufacturing | 2,566 out of 3,314 | 23rd |
Major group Chemicals And Allied Products | 579 out of 746 | 22nd |
Industry group Drugs | 411 out of 546 | 25th |
Industry Biological Products, Except Diagnostic Substances | 81 out of 118 | 31st |
Source: SEC filing on April 1, 2010.
Frost's colleagues
We found five more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2007.
2007
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2007
William Fallon
Halozyme Therapeutics
Vice President Manufacturing and Operations
2007
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2007
Richard Yocum
Halozyme Therapeutics
Vice President — Clinical Development and Medical Affairs
2007
David Ramsay
Halozyme Therapeutics